<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03756337</url>
  </required_header>
  <id_info>
    <org_study_id>PIC-20</org_study_id>
    <nct_id>NCT03756337</nct_id>
  </id_info>
  <brief_title>Neuro 1 vs. Neuro 2 Sound Processors</brief_title>
  <official_title>Comparison of Audiometric Performance Between the Neuro 1 and Neuro 2 Sound Processors.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oticon Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oticon Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the benefit of Neuro 1 sound processor upgrade in speech perfomance in
      adults. Half of participants will be tested with Neuro 1 first and Neuro 2, while the other
      half will be tested with Neuro 2 first and then Neuro 1.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Neuro 1 processor represented a technological advancement over past models, particularly
      in detecting the environment and automatically adjusting to the sound environment. A second
      version of the Neuro 1 processor has been developed, the Neuro 2. The signal processing and
      stimulation characteristics are similar, so speech comprehension levels are expected to be
      equivalent. This study is designed to compare Neuro 1 and Neuro 2 in terms of audiometric
      performance.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>speech recognition in quiet</measure>
    <time_frame>Day 1</time_frame>
    <description>Hearing In Noise Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>speech recognition in noise</measure>
    <time_frame>Day 1</time_frame>
    <description>Hearing In Noise Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pure tone threshold</measure>
    <time_frame>Day 1</time_frame>
    <description>from 250Hz to 8kHz</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hearing Loss, Sensorineural</condition>
  <condition>Cochlear Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Neuro 2 Upgrade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant wears Neuro 1 sound processor and is tested, then is upgraded with the new sound processor Neuro 2 and tested.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neuro 1 Downgrade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant wears Neuro 2 sound processor and is tested, then is downgraded with the sound processor Neuro 1 and tested.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuro 1 &amp; Neuro 2</intervention_name>
    <description>participant common fitting map used for tests</description>
    <arm_group_label>Neuro 2 Upgrade</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuro 2 &amp; Neuro 1</intervention_name>
    <description>participant common fitting map used for tests</description>
    <arm_group_label>Neuro 1 Downgrade</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  written informed consent

          -  primary implantation

          -  subject having participated to previous Neuro 1 sound processor study in Canada

          -  fluent in English, including reading and writing.

        Exclusion Criteria:

          -  psychologically unsuitable

          -  unrealistic expectations regarding possible benefits, risks, and limitations that are
             inherent to the device

          -  non compliant with all investigational requirements.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Peter Morris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dalhousie University, Halifax,NS, Canada</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sonia Saai</last_name>
    <phone>+33493951818</phone>
    <email>sosa@oticonmedical.com</email>
  </overall_contact>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 26, 2018</study_first_submitted>
  <study_first_submitted_qc>November 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2018</study_first_posted>
  <last_update_submitted>November 28, 2018</last_update_submitted>
  <last_update_submitted_qc>November 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cochlear implant</keyword>
  <keyword>sound processor</keyword>
  <keyword>upgrade</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

